Education
About Us
Working with TipRanks
Follow Us
HilleVax, Inc (HLVX)
NASDAQ:HLVX
Total Valuation
HilleVax, Inc has a market cap or net worth of $97.78M. The enterprise value is ―.
Market Cap$97.78M
Enterprise Value―
Share Statistics
HilleVax, Inc has 50,141,064 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding50,141,064
Owned by Insiders3.88%
Owned by Institutions61.14%
Financial Efficiency
HilleVax, Inc’s return on equity (ROE) is -0.95 and return on invested capital (ROIC) is -86.37%.
Return on Equity (ROE)-0.95
Return on Assets (ROA)-0.76
Return on Invested Capital (ROIC)-86.37%
Return on Capital Employed (ROCE)-0.88
Revenue Per Employee0.00
Profits Per Employee-10.52M
Employee Count14
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of HilleVax, Inc is -0.69. HilleVax, Inc’s PEG ratio is -0.06.
PE Ratio-0.69
PS Ratio0.00
PB Ratio0.43
Price to Fair Value0.66
Price to FCF-0.62
Price to Operating Cash Flow-0.70
PEG Ratio-0.06
Income Statement
In the last 12 months, HilleVax, Inc had revenue of 0.00 and earned -147.27M in profits. Earnings per share was -3.00.
Revenue0.00
Gross Profit0.00
Operating Income-155.29M
Pretax Income-147.27M
Net Income-147.27M
EBITDA-155.29M
Earnings Per Share (EPS)-3.00
Cash Flow
In the last 12 months, operating cash flow was -112.21M and capital expenditures -16.48M, giving a free cash flow of -128.68M billion.
Operating Cash Flow-112.21M
Free Cash Flow-128.68M
Free Cash Flow per Share-2.57
Dividends & Yields
HilleVax, Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.59
52-Week Price Change-86.64%
50-Day Moving Average1.80
200-Day Moving Average1.84
Relative Strength Index (RSI)54.39
Average Volume (3m)225.63K
Important Dates
HilleVax, Inc upcoming earnings date is Aug 7, 2025, TBA Not Confirmed.
Last Earnings DateMay 8, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend Date―
Financial Position
HilleVax, Inc as a current ratio of 10.84, with Debt / Equity ratio of 13.55%
Current Ratio10.84
Quick Ratio10.84
Debt to Market Cap0.24
Net Debt to EBITDA0.84
Interest Coverage Ratio46.80
Taxes
In the past 12 months, HilleVax, Inc has paid -147.27M in taxes.
Income Tax-147.27M
Effective Tax Rate0.00
Enterprise Valuation
HilleVax, Inc EV to EBITDA ratio is 0.18, with an EV/FCF ratio of 0.26.
EV to Sales0.00
EV to EBITDA0.18
EV to Free Cash Flow0.26
EV to Operating Cash Flow0.26
Balance Sheet
HilleVax, Inc has $189.31M in cash and marketable securities with $24.97M in debt, giving a net cash position of -$164.34M billion.
Cash & Marketable Securities$189.31M
Total Debt$24.97M
Net Cash-$164.34M
Net Cash Per Share-$3.28
Tangible Book Value Per Share$3.14
Margins
Gross margin is 22.28%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin22.28%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for HilleVax, Inc is $2.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$2.00
Price Target Upside2.56% Upside
Analyst ConsensusHold
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast1.27%